Balance Sheet
Accounts PayablesCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EUDA Health Holdings (EUDA) Other Accumulated Expenses (2022 - 2025)

Historic Other Accumulated Expenses for Health Holdings (EUDA) over the last 4 years, with Q2 2025 value amounting to $614982.0.

  • Health Holdings' Other Accumulated Expenses rose 619.32% to $614982.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $614982.0, marking a year-over-year increase of 619.32%. This contributed to the annual value of $555406.0 for FY2024, which is 2025.7% down from last year.
  • Health Holdings' Other Accumulated Expenses amounted to $614982.0 in Q2 2025, which was up 619.32% from $555406.0 recorded in Q4 2024.
  • In the past 5 years, Health Holdings' Other Accumulated Expenses ranged from a high of $1.5 million in Q4 2022 and a low of $555406.0 during Q4 2024
  • Over the past 4 years, Health Holdings' median Other Accumulated Expenses value was $655738.5 (recorded in 2023), while the average stood at $816082.8.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first crashed by 5423.65% in 2023, then skyrocketed by 619.32% in 2025.
  • Health Holdings' Other Accumulated Expenses (Quarter) stood at $1.5 million in 2022, then tumbled by 54.24% to $696495.0 in 2023, then decreased by 20.26% to $555406.0 in 2024, then grew by 10.73% to $614982.0 in 2025.
  • Its Other Accumulated Expenses stands at $614982.0 for Q2 2025, versus $555406.0 for Q4 2024 and $579116.0 for Q2 2024.